Medical News: ACR: Saving Knees from OA May Break the Bank - in Meeting Coverage, ACR from MedPage Today

Image via Wikipedia

By John Gever, Senior Editor, MedPage Today

Drugs intended to prevent osteoarthritis of the knee can realistically be cost-effective only if the annual expense per patient is substantially less than $1,000, researchers said here.

The limit was identified by computer modeling using multiple data inputs and the World Health Organization's reference standard for cost-effectiveness of $144,000 per quality-adjusted life-year (QALY) in the U.S., said Elena Losina, PhD, of Brigham and Women's Hospital in Boston.
Continue Reading